A Comparison of Allografting with Autografting for Newly Diagnosed Myeloma

2007504 citationsJournal Article

Authors

Benedetto Bruno · University of Turin

Marcello Rotta · University of Turin

Francesca Patriarca · University of Udine

Nicola Mordini · Carle Foundation Hospital

Bernardino Allione · Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

Fabrizio Carnevale‐Schianca · Candiolo Cancer Institute

Luisa Giaccone

Abstract

Among patients with newly diagnosed myeloma, survival in recipients of a hematopoietic stem-cell autograft followed by a stem-cell allograft from an HLA-identical sibling is superior to that in recipients of tandem stem-cell autografts. (ClinicalTrials.gov number, NCT00415987 [ClinicalTrials.gov].).

Topics & Keywords

Multiple Myeloma Research and Treatments Hematopoietic Stem Cell Transplantation Histone Deacetylase Inhibitors Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 356, Issue 11, pp. 1110-1120

DOI: 10.1056/nejmoa065464

Field-Weighted Citation Impact: 29.34